# OVTZ (Oculus Inc.) - SEC EDGAR Financial Statements

> Oculus Inc. reported $27K in total assets and a net loss of $263K through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/OVTZ
- Markdown: https://convexityos.com/fundamentals/OVTZ.md
- SEC CIK: 0001107280
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001107280&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -- | Operating profit |
| Net Income | FY 2025 | -$263K | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $9.4K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| Research & Development | $1.0K | $6.9K | $96K | $1.14M | $818K | $254K | -- | $4.8K | $81K | $240K |
| Selling, General & Admin | $258K | $224K | $274K | $399K | $431K | $267K | $197K | $179K | $150K | $213K |
| **Operating Income** | -- | -- | -- | -$2.07M | -$1.99M | -$2.77M | -$197K | -$183K | -$231K | -$453K |
| Income Before Tax | -$319.1M | -$327.4M | -$591K | -$1.65M | -$1.99M | -$2.77M | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- | -- | -- |
| **Net Income** | -$319K | -$327K | -$591K | -$1.65M | -$1.99M | -$2.77M | -$193K | -$183K | -$231K | -$453K |
| Basic EPS | $0.00 | $0.00 | -$0.01 | -$0.02 | -$0.02 | -$0.04 | -- | $0.00 | -$0.01 | -$0.01 |
| **Diluted EPS** | -- | -- | -- | -- | -$0.02 | -$0.04 | -- | $0.00 | -$0.01 | -$0.01 |
| Basic Shares Outstanding | 91.4M | 91.4M | 91.4M | 91.4M | 90.0M | 75.4M | 57.0M | 45.6M | 45.6M | 45.6M |
| Diluted Shares Outstanding | -- | -- | -- | -- | 90.0M | 75.4M | 57.0M | 45.6M | 45.6M | 45.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.5K | $276 | $270 | $272 | $276 | $183 | $277 | $740 |
| Selling, General & Admin | $49K | $47K | $47K | $56K | $78K | $37K | $88K | $79K |
| **Net Income** | -$67K | -$63K | -$62K | -$71K | -$93K | -$52K | -$103K | -$95K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 91.4M | 91.4M | 91.4M | -- | 91.4M | 91.4M | 91.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $9.4K | $12K | $157K | $688K | $12K | $490K | $382K | $5.6K | -- | $6.4K |
| **Cash & Short-Term Investments** | $9.4K | $12K | $157K | $688K | $12K | $490K | $382K | $5.6K | -- | $6.4K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Total Current Assets** | -- | -- | -- | -- | -- | -- | $384K | $6.8K | $29K | $69K |
| **Total Non-Current Assets** | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| **Total Assets** | $32K | $40K | $184K | $718K | $40K | $496K | $384K | $6.8K | $29K | $69K |
| Accounts Payable | -- | -- | -- | $225K | $62K | $17K | $5.0K | $29K | $18K | $52K |
| **Total Current Liabilities** | $770K | $449K | $274K | $302K | $449K | $168K | $135K | $742K | $581K | $390K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $770K | $449K | $274K | $302K | $449K | $168K | $135K | $742K | $581K | $390K |
| Common Stock | $46.85M | $46.85M | $46.85M | $46.85M | $46.85M | $43.79M | $41.63M | $40.46M | $40.46M | $40.46M |
| Retained Earnings | -$49.03M | -$48.71M | -$48.39M | -$47.80M | -$48.71M | -$44.16M | -$41.39M | -$41.19M | -$41.01M | -$40.78M |
| Accumulated Other Comp. Income | -- | -$31K | -$33K | -- | -- | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | -$738K | -$409K | -$90K | $415K | -$409K | $328K | $248K | -$736K | -$552K | -$322K |
| Total Equity | -$738K | -$409K | -$90K | $415K | -$409K | $328K | $248K | -$736K | -$552K | -$322K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $9.4K | $5.0K | $17K | $9.4K | $15K | $8.2K | $8.1K | $12K |
| **Cash & Short-Term Investments** | $9.4K | $5.0K | $17K | $9.4K | $15K | $8.2K | $8.1K | $12K |
| **Total Assets** | $27K | $21K | $36K | $32K | $25K | $24K | $44K | $40K |
| **Total Current Liabilities** | $944K | $871K | $829K | $770K | $692K | $596K | $556K | $449K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $944K | $871K | $829K | $770K | $692K | $596K | $556K | $449K |
| Common Stock | $46.85M | $46.85M | $46.85M | $46.85M | $46.85M | $46.85M | $46.85M | $46.85M |
| Retained Earnings | -$49.22M | -$49.16M | -$49.10M | -$49.03M | -$48.96M | -$48.87M | -$48.82M | -$48.71M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | -$31K |
| **Total Stockholders' Equity** | -$916K | -$850K | -$793K | -$738K | -$667K | -$572K | -$513K | -$409K |
| Total Equity | -$916K | -$850K | -$793K | -$738K | -$667K | -$572K | -$513K | -$409K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$319K | -$327K | -$591K | -$1.65M | -$1.99M | -$2.77M | -$193K | -$183K | -$231K | -$453K |
| Stock-Based Compensation | $0 | $6.0K | $84K | $397K | $714K | $285K | -- | -- | -- | -- |
| **Operating Cash Flow** | $6.9K | -$147K | -$533K | -$1.48M | -$1.35M | -$779K | -$800K | $5.6K | -$6.4K | -$181K |
| **Investing Cash Flow** | -- | -- | -- | $5.2K | $0 | $114K | -- | -- | -- | -- |
| Common Stock Issued | -- | -- | -- | $0 | $3.10M | $773K | $1.18M | -- | -- | -- |
| **Financing Cash Flow** | -- | -- | -- | $0 | $3.06M | $773K | $1.18M | -- | -- | -- |
| **Net Change in Cash** | -$2.3K | -$145K | -$531K | -$1.52M | $1.72M | $108K | $377K | $5.6K | -$6.4K | -$181K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$67K | -$63K | -$62K | -$71K | -$93K | -$52K | -$103K | -$95K |
| Stock-Based Compensation | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Operating Cash Flow** | $4.3K | -$18K | $734 | -$6.7K | $8.8K | $8.0K | -$3.3K | $5.5K |
| **Net Change in Cash** | $4.4K | -$12K | $7.2K | -$5.8K | $7.0K | $102 | -$3.6K | $8.2K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -397.1% | -- | -844.7% | -77.7% | -- | -- | -- |
| Return on Assets (ROA) | -991.3% | -827.9% | -321.4% | -229.8% | -5024.4% | -558.7% | -50.3% | -2709.6% | -799.1% | -660.9% |
| Current Ratio | -- | -- | -- | -- | -- | -- | 2.83x | 0.01x | 0.05x | 0.18x |
| Quick Ratio | 0.01x | 0.03x | 0.57x | 2.27x | 0.03x | 2.92x | 2.82x | 0.01x | -- | 0.02x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -- | -- | -100.0% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -14454.3% | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | -- | -- | -100.0% | -100.0% | -100.0% | -100.0% |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -158.3% | -120.2% | -- |
| 10Y Net Income / Share Growth | -- | -- | -193.8% | -171.8% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -958.1% | -1354.8% | -775.6% | -991.3% | -1359.7% | -1341.4% | -795.9% | -827.9% |
| Quick Ratio | 0.01x | 0.01x | 0.02x | 0.01x | 0.02x | 0.01x | 0.01x | 0.03x |
| Operating Cash Flow Growth (YoY) | -51.9% | -321.3% | -- | -220.2% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
